0.32 USD
-0.01 (-3.03%)
AT CLOSE (11:59 AM EDT)
Mereo BioPharma Group plc American Depositary Shares (MREO)
NASDAQ: MREO • USD
0.32
+0.01 (+1.88%)
POST MARKET (AS OF 04:11 PM EDT)
Market: OPEN
Open?$0.33
High?$0.34
Low?$0.32
Prev. Close?$0.33
Volume?2.2M
Avg. Volume?N/A
VWAP?$0.33
Bid / Ask
Bid?$0.32 × 200
Ask?$0.35 × 100
Spread?$0.03
Midpoint?$0.33
Valuation & Ratios
Market Cap?52.7M
Shares Out?159.1M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
Employees
39
Market Cap
52.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2018-04-24
Address
ONE CAVENDISH PLACE
LONDON, W1G 0QF
Phone: 4403330237300
LONDON, W1G 0QF
Phone: 4403330237300